From left: Richard P. Warner, MD, and Edward M. Wolin, MD
A conference room at the Icahn School of Medicine at Mount Sinai was the setting for a passing-of-the-gavel ceremony held on Friday, January 5, which formalized the new leadership of Mount Sinai’s Center for Carcinoid and Neuroendocrine Tumors. Richard P. Warner, MD, Professor of Medicine (Gastroenterology), who founded the Center and established its reputation for world-class research and treatment of neuroendocrine tumors, officially passed the gavel to his longtime mentee and esteemed colleague Edward M. Wolin, MD, who will begin leading the Center in March. Dr. Wolin currently serves as Director of the Neuroendocrine Tumor Program at Montefiore Einstein Center for Cancer Care.
Michelle Kang Kim, MD, PhD, Associate Professor of Medicine (Gastroenterology), who has served as the Center’s Interim Director and will be the Center’s Associate Director after Dr. Wolin’s arrival, presided over the passing-of-the-gavel ceremony, which was attended by the Center’s multidisciplinary team of specialists that includes gastroenterologists, radiologists, surgeons, hematologists/oncologists, and cardiologists, among other specialties.